Project Grant HT94252410282
Award Date
6/1/24
Completion Date
5/31/27
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Awardee
Duke University (TP7EK8DZV6N5)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Durham, NC 27705, USA
Similar Awards
The Defense Health Agency awarded Duke University a $402,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2023 through May 31, 2025. The grant will support Duke University's research efforts to target the ferropotosis protection mechanism of serum to disable cancer metastasis. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions for both...
The Defense Health Agency awarded Duke University a $804,999 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research on "DETECTING MISSED METASTASES FROM NOMINALLY EARLY-STAGE MELANOMAS WITH PUMP-PROBE MICROSCOPY". The award runs from September 1, 2023 to August 31, 2026. The Project Grant enables Duke's research to transform health care for Service Members and the American public through innovative and impactful biomedical research...
Duke University was awarded a $931,969 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 to develop epigenetic signatures to predict pathological nodal stage for de-escalation of axillary surgery in patients with clinically node-positive breast cancer. The research aims to transform patient care by investigating medical solutions that could help reduce the need...
The federal Project Grant award of $481,158.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) enables Duke University to conduct research aimed at "Blocking Glutamine Utilization in Advanced and Therapy-Resistant Prostate Cancer." The award supports a two-year project from June 1, 2024 to May 31, 2026 to expand the frontiers of scientific knowledge and apply it to address a critical medical challenge facing military service...
The Defense Health Agency awarded Duke University a $3,811,150.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct a research project titled "SINGLE-CELL AND SPATIAL ANALYSIS OF LETHAL BREAST CANCERS". The grant period runs from April 1, 2024 to March 31, 2028. The key products and services to be delivered under this award include comprehensive single-cell and spatial analysis of breast cancer samples to characterize tumor heterogeneity...
The Defense Health Agency awarded a $828,591 Project Grant under CFDA 12.420, the Military Medical Research and Development program, to Duke University. The grant supports research titled "Targeting the Tumor Microenvironment to Enhance Immunotherapy for SCLC", with a performance period from May 1, 2025 to April 30, 2027. This research aims to transform healthcare for military service members, veterans, and the public by advancing innovative biomedical investigations focused on...
The Defense Health Agency awarded Duke University a $759,627.49 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "ACCELERATED AGING IN GULF WAR ILLNESS: PHENOTYPES, EPIGENETIC BIOMARKERS, AND ASSOCIATIONS WITH GULF WAR EXPOSURES." The project will run from August 1, 2023 to July 31, 2026. Duke University, a top-ranked global research institution, will be the prime awardee and perform the research through its Office of...
The Department of Defense's Defense Health Agency awarded a $1,182,931 Project Grant to Duke University on February 1, 2024 under the Military Medical Research and Development program (CFDA 12.420). The grant supports a 3-year project focused on "NK CELL RESPONSE AS A CLINICAL DIFFERENTIATOR OF ENDOCRINE THERAPIES" that will be conducted at Duke University's Office of Research Administration Division. This research aims to improve understanding of the clinical implications of natural...
The U.S. Department of Defense's Defense Health Agency awarded a $845,250 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Duke University. The grant, with a performance period from July 1, 2025 to June 30, 2028, will fund research to engineer TCR-T cells to target human endogenous retroviruses for non-small cell lung cancer immunotherapy. The goal of this advanced biomedical research is to transform healthcare for military service members, veterans, and...
The Department of Defense's Defense Health Agency awarded Duke University a $1,344,946 Project Grant on September 1, 2023 through the Military Medical Research and Development program (CFDA 12.420). This grant supports a 3-year research project titled "Understanding Heterogeneity and Improving the Precision of Prostate Cancer Clinical Outcomes in the Modern Era." The research aims to advance understanding and treatment of prostate cancer, with a focus on improving clinical outcomes for...